Hims & Hers' lower-priced injectable semaglutide promoted during the Super Bowl has led to some patients receiving the more ...
Whether you have type 2 diabetes, obesity or just a few extra pounds that you’d like some help shedding, chances are you’re ...
The telehealth company Hims & Hers has made waves for its Super Bowl ad that plugged its lower-priced form of injectable ...
New diabetes medications are pressuring Medicare Part D financially as they drive up prescription drug costs amid rising ...
Finally, a study of 154 people on metformin for weight loss found that participants lost an average of 5.6 to 7 kg (that’s ...
While one study found lower rates of preterm birth alongside higher rates of hypertensive disorders, another found fewer ...
Daily metformin with or without a Mediterranean ... CKD The FDA has approved a new indication for semaglutide to lower the risk for worsening kidney disease, kidney failure and cardiovascular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results